Knapp J Z, Abramson L R
R & D Associates, Inc, Somerset, New Jersey.
J Pharm Sci Technol. 1994 May-Jun;48(3):110-34.
The prerequisites for estimating the effect of signal coincidence on both particle undercounting and the injection of false counts in the implementation of U.S.P. 788 contaminating particle assays by light extinction particle counters are defined. These include a particle concentration measure that varies with particle size and a new model of the counting process. Both prerequisites have been verified empirically: a single normalized equation describes the coincidence effect in all single particle counters. The single parameter of the normalized equation is the number of effective detector volumes per milliliter. A maximum undercount limit of 5% is proposed based on adequately suspended particles. Using the SVP U.S.P. XXII acceptance limits of 10,000 particles per container or the PMA propose 6,000 particles per container maximum for particles > 10 microns in U.S.P. XXIII, undercount errors are estimated for the smallest container sizes. The large concentration of particles below the controlled 10 microns particle size, that has been documented in injectable solutions, can pose an additional 788 measurement hazard. A Poisson model is used to estimate and control the injection of false particle counts into the mandated measurement through particle coincidence. Acceptable counting accuracy limits with present particle counting systems can be achieved by understanding the capabilities of the particle counter measurement system and using a dilution technique when appropriate. The new model of the counting process and the new particle concentration measures can result in standard, conservative, instrument specifications for use in Pharmacopeial contamination testing and in GLP user evaluation tests. Part I of this paper includes the theory of the coincidence effect on particle counting and the particle size distribution measured. A summary of the experimental verification employed to determine coincidence count loss as a function of particle concentration for single particle counters is reported. Part II of this paper describes a practical protocol for the determination of operating limits to achieve a selected coincidence undercount limit for single particle counters.
定义了在美国药典788中采用光散射粒子计数器进行污染粒子检测时,估算信号重合对粒子计数不足及错误计数注入影响的前提条件。这些条件包括一个随粒径变化的粒子浓度测量值和一种新的计数过程模型。这两个前提条件均已通过实验验证:一个单一的归一化方程描述了所有单粒子计数器中的重合效应。归一化方程的单一参数是每毫升有效检测体积的数量。基于充分悬浮的粒子,提出了5%的最大计数不足限制。使用美国药典XXII每容器10,000个粒子的SVP验收限度,或美国药典XXIII中针对大于10微米粒子每容器最多6,000个粒子的PMA建议,估算了最小容器尺寸下的计数不足误差。已记录在注射用溶液中的低于受控10微米粒径的大量粒子,可能会给788测量带来额外风险。采用泊松模型来估算和控制因粒子重合而向强制测量中注入错误粒子计数的情况。通过了解粒子计数器测量系统的能力并在适当情况下使用稀释技术,可实现当前粒子计数系统可接受的计数精度限度。计数过程的新模型和新的粒子浓度测量方法可得出用于药典污染检测和GLP用户评估测试的标准、保守的仪器规格。本文第一部分包括重合效应在粒子计数及所测粒径分布方面的理论。报告了用于确定单粒子计数器中重合计数损失作为粒子浓度函数的实验验证总结。本文第二部分描述了一种实用方案,用于确定操作限度,以实现单粒子计数器选定的重合计数不足限制。